IntroductionInnovation for competitiveness: Driving adoption of AI-based digital medical devices
Main stage - C1
Mar 26, 2026
1:15 PM1:20 PM
Introduction
Main stage - C1
Mar 26, 2026
1:20 PM1:30 PM
Welcome address
MG
MarioGrotz
LuxinnovationCEO
Main stage - C1
Mar 26, 2026
1:30 PM1:45 PM
Opening speech
LD
LexDelles
Minister of the Economy, SMEs, Energy and TourismMinister
Main stage - C1
Mar 26, 2026
1:45 PM2:00 PM
Keynote address
SG
SandraGallina
EU CommissionDirector-General for Health and Food Safety
Session 1: Need-driven innovation of digital medical devices: Addressing real challenges
While digital medical devices — particularly those powered by AI — raise new expectations of enhanced healthcare system efficiency and care transformation, many yet struggle to gain traction. Why? Because they fail to address the real, unmet needs of patients, healthcare professionals and health systems. This session explores how healthtech innovators can identify and qualify genuine clinical and operational needs in order to translate them into innovations with solid value propositions.
Main stage - C1
Mar 26, 2026
2:00 PM2:15 PM
AI technologies in healthcare: Hype or hope?
SR
SailaRinne
DG ConnectHead of Unit “Artificial Intelligence in Health and Life Sciences”
Main stage - C1
Mar 26, 2026
2:15 PM2:30 PM
Needs-driven innovation: How to create your toolbox
Luxembourg Institute of healthDirector of Transversal Translational Medicine, Professor of Neurosciences at the University of Luxembourg
DT
DanielTheisen
ALAN a.s.b.l. Maladies Rares LuxembourgDirector
SR
SailaRinne
DG ConnectHead of Unit “Artificial Intelligence in Health and Life Sciences”
Foyer
Mar 26, 2026
3:20 PM3:45 PM
Coffee break
Session 2: Medical Device Regulation and AI Act: Leveraging value of innovation
Navigating complex regulations can be challenging for healthtech innovators — but as a gatekeeper of quality and safety, EU regulations are a powerful proof of the reliability and trustworthiness of digital medical devices. Leveraging on the ongoing MDR revision and the implementation of the AI Act, this session discusses how to turn evidence-based development and regulatory compliance into value that will result in a market advantage, and explores how regulators can uphold high standards without hindering innovation.
Main stage - C1
Mar 26, 2026
3:45 PM4:00 PM
Medical Device Regulation revision: Boost or barrier to market access and global competitiveness?
FG
FloraGiorgio
DG SANTEHead of Unit D3Medical Devices
Main stage - C1
Mar 26, 2026
4:00 PM4:15 PM
Valuing AI in medical devices: A common challenge for regulators and innovators
RSI
RuiSantos Ivo
INFARMED, EMA, HAGPresident of the Executive Board of INFARMED – National Authority of Medicines and Health Products, I.P.
Main stage - C1
Mar 26, 2026
4:15 PM5:05 PM
Round table – Digital medical devices: Is the EU still attractive for a first market launch?
RSI
RuiSantos Ivo
INFARMED, EMA, HAGPresident of the Executive Board of INFARMED – National Authority of Medicines and Health Products, I.P.
SL
SandrineLavalle
EUPATI Luxembourg & Luxembourg Institute of HealthChair of the EUPATI National Platform Cluster & PPI Manager
AC
AnnaChioti
Luxembourg Health Directorate - Direction de la SantéHead of Division Pharmacy and Medicines
FG
FloraGiorgio
DG SANTEHead of Unit D3Medical Devices
TE
TirionEvans
ScarletHead of Notified Body & Technical Operations
LA
LizAshall-Payne
ORCHAFounder
Day 1 closing & networking
Main stage - C1
Mar 26, 2026
5:05 PM5:15 PM
Day 1 Key take aways
B2B Area
Mar 26, 2026
5:15 PM7:00 PM
B2B meetings
Foyer
Mar 26, 2026
5:15 PM7:00 PM
Networking cocktail
Day 2
Programme 27 March
Foyer
Mar 27, 2026
8:00 AM8:50 AM
Registration and breakfast
Main stage - C1
Mar 27, 2026
8:50 AM9:00 AM
Day 2 kick-off
MW
MarcoWendel
Medical ValleyManaging Director, COO & CFO
Session 3:Usability of digital health solutions: Facilitating adoption today and tomorrow
Widespread adoption of digital medical devices will only happen if they serve their users, rather than adding administrative or practical burdens. This session highlights the importance of making devices intuitive, seamlessly embedded into clinical workflows and interoperable across electronic health records and hospital information systems to ensure their scalability and adoption. However, while AI-based devices have the potential to provide solutions for more efficient and better care, their adoption might require adapting workflows. We also discuss how to support the innovations of today while preparing users for the transformations of clinical and operational workflows of tomorrow.
Main stage - C1
Mar 27, 2026
9:00 AM9:15 AM
Rethinking usability: From convenience to key requirement
ED
EvaDeckers
Catharina Hospital EindhovenDirector of Strategy, Transformation and Research
Main stage - C1
Mar 27, 2026
9:15 AM9:30 AM
Ensuring affordability for an effective, inclusive and sustainable adoption
HK
HelmaKaptein
Hogeschool RotterdamProfessor of Healthcare Technology Implementation
Main stage - C1
Mar 27, 2026
9:30 AM10:20 AM
Round table - Adopting disruptive innovation for a healthy transformation of care: Are we ready?
ED
EvaDeckers
Catharina Hospital EindhovenDirector of Strategy, Transformation and Research
SF
ShirleyFeider
CAPAT - Cercle des Associations de PatientsPresident
HK
HelmaKaptein
Hogeschool RotterdamProfessor of Healthcare Technology Implementation
The successful commercial launch of AI-driven digital medical devices requires trust. This session explores how to gain the confidence of key stakeholders — investors, clinicians, patients, regulators and payers — by clearly demonstrating the needs addressed, value, usability, accessibility and affordability of solutions. We also outline the key role of effective communication, marketing and training strategies that underpin a compelling and competitive business case ready for the EU market.
Main stage - C1
Mar 27, 2026
10:40 AM10:55 AM
Building trust: What are the key ingredients?
FR
FelicitasRiedl
European Investment Bank (EIB)Director of the Innovation and Competitiveness Department
Main stage - C1
Mar 27, 2026
10:55 AM11:10 AM
Communication and training of end-users: necessary for digital medical device adoption?
AO
AlexanderOlbrechts
MedTech EuropeDirector Digital Health & Medtech Value
Main stage - C1
Mar 27, 2026
11:10 AM12:00 PM
Round table - Innovation, regulation and competitiveness: How can Europe take the lead
DC
DavidCaumartin
RebrAInCEO
MG
MarioGrotz
LuxinnovationCEO
VS
ValentinaStrammiello
European Patient Forum InterimExecutive Director
SBVR
SigridBerge van Rooijen
Eir HealthHealth AI Consultant
AO
AlexanderOlbrechts
MedTech EuropeDirector Digital Health & Medtech Value
FR
FelicitasRiedl
European Investment Bank (EIB)Director of the Innovation and Competitiveness Department
Day 2 closing & networking
Main stage - C1
Mar 27, 2026
12:00 PM12:10 PM
Closing remarks
SO
StéphanieObertin
Minister for Digitalisation, Research and Higher Education